Faraz Ali

Chief Executive Officer • Tenaya Therapeutics

Mr. Ali was most recently chief business officer at REGENXBIO, where he had accountability for corporate development, commercial planning, portfolio strategy, alliance management and corporate communications. Prior to that, he was a vice president at bluebird bio, where he had accountability for new product planning, program management, patient advocacy and external affairs. Mr. Ali also had roles of increasing global commercial leadership at Genzyme Corporation, where he helped launch multiple first-in-class enzyme replacement therapies for rare diseases. He started his career at General Electric, including technical roles at GE Healthcare and business assignments at GE Corporate. Mr. Ali received his MBA. from Harvard Business School and his B.S. from Stanford University.

Also Speaking

Øystein Åmellem

Director, Cell Biology • Thermo Fisher Scientific Inc

Lee Buckler

Amritha Jaishankar

Executive Director, Cell and Gene Therapy Center • IQVIA

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.